View in EDS HTML Full Text PDF Full Text

A real-world multicenter study of first-line zanubrutinib-based therapy for diffuse large B-cell lymphoma.

Saved in:
Bibliographic Details
Title: A real-world multicenter study of first-line zanubrutinib-based therapy for diffuse large B-cell lymphoma.
Authors: Hu, Lina1,2 (AUTHOR), Lu, Bo3 (AUTHOR), Wei, Xiaolei4 (AUTHOR), Wang, Ying5 (AUTHOR), Xie, Mian6 (AUTHOR), Li, Jun1 (AUTHOR), Feng, Chun1 (AUTHOR), Li, Guoqiang1 (AUTHOR), Qiu, Xiao1 (AUTHOR), Zhang, Jiahe1 (AUTHOR), Guo, Xutao4 (AUTHOR), Zhong, Zhiren2 (AUTHOR), Li, Xiaoqing7 (AUTHOR) 18620385718@163.com, Zhang, Qian8 (AUTHOR) herpes@126.com, Zhou, Jihao1 (AUTHOR) zhoujihao@aliyun.com
Source: Leukemia & Lymphoma. Jul2026, Vol. 67 Issue 8, p1707-1714. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10428194
DOI:10.1080/10428194.2026.2654977